Aller au contenu principal

Journée Microbiotes et Santé 2025

23 janv. 2025 | Lyon, France

S'inscrire
S'inscrire
S'inscrire

Nigel Titford

CEO, BioGaia Pharma AB & Head of Business Development, BioGaia AB

BioGaia AB

Stockholm, Suède

2 visites de profilIntervenantLes intervenants

Mon organisation

BioGaia AB

BioGaia AB

Grands groupes

Stockholm, Suède

BioGaia is a Swedish probiotic company that has been at the forefront of microbiome research for more than 30 years. BioGaia develops, markets and sells probiotic products within the areas of gut, oral, immune and bone health. Our probiotic products with bacterial strains from the L. reuteri species are among the most scientifically well-documented probiotics. The class B share of BioGaia is quoted on the Mid Cap list of the Nordic Exchange Stockholm.
En savoir plus

Sur moi

Nigel has worked for 25 years in the probiotics and microbiome fields, from the early days of developing BioGaia’s first dietary supplement products, through developing partnerships within infant and medical nutrition and establishing the company’s business in North America and Asia.  In 2017 he cofounded BioGaia Pharma AB set up as an incubator for pharmaceutical candidates selected from BioGaia’s ongoing research & discovery programs, two of which are now in early phase clinical development.  His role in Business Development for the parent company involves looking for strategic partnerships, and in-licensing and acquisition opportunities to supplement the product pipeline of the core business and to help grow BioGaia’s biotics business in new directions.

Mon organisation

BioGaia AB

BioGaia is a Swedish probiotic company that has been at the forefront of microbiome research for more than 30 years. BioGaia develops, markets and sells probiotic products within the areas of gut, oral, immune and bone health. Our probiotic products with bacterial strains from the L. reuteri species are among the most scientifically well-documented probiotics. The class B share of BioGaia is quoted on the Mid Cap list of the Nordic Exchange Stockholm.

Sessions d'intervenants 1

jeudi 23 janvier 2025

11:00 - 12:15

Session Illustration

Format :Sur placeTrack :Conférences

2 intervernants : TBD - MaaT Pharma | TBD